Terms: = Lung cancer AND TRA AND Prognosis
1 results:
1. A phase II trial of a differentiating agent (tra) with cisplatin-VP 16 chemotherapy in advanced non-small cell lung cancer.
Thiruvengadam R; Atiba JO; Azawi SH
Invest New Drugs; 1996; 14(4):395-401. PubMed ID: 9157076
[TBL] [Abstract] [Full Text] [Related]
